The IARC Monographs Program – sowing public confusion, controversy, and criticism: a commentary
Journal of Toxicology and Regulatory Policy · 2025
DOI: 10.69982/jtrp-25-0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Toxicology and Regulatory Policy, 2025. Verfasst von David B. Fischer. Gefördert von: Center for Truth in Science.
Abstract (Originalsprache)
This article focuses on the Monographs Program, established to address the growing need for cancer classifications of chemicals and other agents. Part I provides an overview of the Program, its global impact, and how International Agency for Research on Cancer’s (IARC) cancer classifications are relied on by U.S. regulatory agencies. Part II discusses two controversial cancer classification decisions involving glyphosate and aspartame, both of which serve to showcase the Monographs Program’s persistent and controversial decision-making process. Indeed, the Program’s cancer classifications continue to roil U.S. federal agencies.
Förderung
- Center for Truth in Science
Zitieren
APA
Fischer, D. B. (2025). The IARC Monographs Program – sowing public confusion, controversy, and criticism: a commentary. Journal of Toxicology and Regulatory Policy. https://doi.org/10.69982/jtrp-25-0003
Vancouver
Fischer DB. The IARC Monographs Program – sowing public confusion, controversy, and criticism: a commentary. Journal of Toxicology and Regulatory Policy. 2025. doi:10.69982/jtrp-25-0003
BibTeX
@article{Fischer2025,
author = {Fischer, David B.},
title = {The IARC Monographs Program – sowing public confusion, controversy, and criticism: a commentary},
journal = {Journal of Toxicology and Regulatory Policy},
year = {2025},
doi = {10.69982/jtrp-25-0003}
}
EUVIMED